Working… Menu

To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04541485
Recruitment Status : Terminated (Enrolment was suspended since 09Dec2020 due to a lack of COVID-19 patients.)
First Posted : September 9, 2020
Last Update Posted : September 23, 2021
Information provided by (Responsible Party):
Daewoong Pharmaceutical Co. LTD.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 3, 2021
Actual Study Completion Date : March 23, 2021